Lobbying

Extremity Care's latest lobbying report covers Q4 2024, at under $5,000. Its first report covers Q2 2024; the issues it reports most are Medical/Disease Research/Clinical Labs.

Extremity Care

Latest quarter
No record
Q2 2026 · 0 reports
Last 12 months
$0
Last 4 quarters
vs last quarter
No record
Q2 2026 against the quarter before
First report
Q2 2024
The first quarter a report named it

Lobbying by quarter

Extremity Care lobbying by quarter
Extremity Care lobbying by quarter
QuarterAmountReports
Q2 2024$130K1
Q3 2024$130K1
Q4 2024$01
Q1 2025$00
Q2 2025$00
Q3 2025$00
Q4 2025$00
Q1 2026$00
Q2 2026$00

Policy issues the reports name

  • Medical research and clinical labs3 reports

A report that names several issues counts once for each.

Who was lobbied

  • Centers For Medicare and Medicaid Services (CMS)3 reports
  • Health & Human Services, Dept of (HHS)3 reports
  • HOUSE OF REPRESENTATIVES3 reports
  • SENATE3 reports

Firms it paid

Firm
Ballard Partners$260K3 quarters

Former officials lobbying for it

Former position
DANIEL MCFAULLegislative Director to U.S. Representative Joe Scarborough; Chief of Staff to U.S. Representatives Jeff Miller and Matt GaetzQ4 2024
MICHAEL LAROSA(Lobbying limited to Congress) EA, Congresswoman Bean; Assistant to DepDir, OPM; Comm Dir, ENRC, Senate; DPCC, Comm Dir, Speaker Pelosi; Biden Harris Transition Team, Press Sec. First Lady; SA to President Biden; Press Sec. First LadyQ4 2024
TOLA THOMPSONCommunications Director and Senior Legislative Assistant to U.S. Representative Carrie Meek (1993-2002); Chief of Staff to U.S. Representative Al Lawson (2017-2021)Q3 2024

Lobbying reports

Filed by
25/01/21for Q4 2024Ballard PartnersUnder $5,000
24/10/17for Q3 2024Ballard Partners$130K
24/07/20for Q2 2024Ballard Partners$130K
24/07/19for Q2 2024Ballard PartnersUnder $5,000
Extremity Care US lobbying spending and firms | Whalegun